Zykalor

Zykalor (aripiprazole) is an intramuscular antipsychotic medication used for acute agitation in schizophrenia or bipolar disorder. This prescription-only injection provides rapid symptom control when oral therapy isn’t feasible. Store at controlled room temperature away from light. Always consult a healthcare provider before use.

Zykalor is used to manage acute agitation in adults with schizophrenia or bipolar I disorder. It helps reduce symptoms like aggression, hostility, and restlessness during psychiatric emergencies. This intramuscular injection offers an alternative when oral medications cannot be administered. It is not intended for long-term maintenance therapy.

Zykalor may help calm agitation and restore behavioral control during psychiatric crises. Patients often experience reduced restlessness and aggression within hours of administration. Common effects include drowsiness, dizziness, or mild injection-site discomfort. These effects vary by individual and typically subside over time.

Zykalor should be administered by a healthcare professional in a controlled setting. Monitor for signs of excessive sedation or movement disorders after injection. Keep emergency medical support available during administration. Patients with a history of seizures or cardiovascular conditions require careful evaluation before use.

Avoid alcohol and central nervous system depressants while using Zykalor, as they may increase sedation. Caution is advised with medications that affect liver enzymes, such as CYP3A4 inhibitors or inducers. Concomitant use with antihypertensives may require blood pressure monitoring. Always disclose all current medications to your healthcare provider.